| P2093 | author name string | Ardissino D | |
| | Merlini PA | |
| P2860 | cites work | Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation | Q70548074 |
| | The isolation and characterization of a specific antibody population directed against the thrombin antithrombin complex | Q70648818 |
| | Thrombin generation in acute promyelocytic leukemia | Q70957061 |
| | Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction | Q71271304 |
| | Persistent activation of coagulation mechanism in unstable angina and myocardial infarction | Q72047945 |
| | Poor comparability of prothrombin fragment 1 + 2 values measured by two commercial ELISA methods: influence of different anticoagulants and standards | Q72202449 |
| | Thrombin generation and myocardial infarction during infusion of tissue-plasminogen activator | Q72210803 |
| | The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men | Q72215564 |
| | Thrombin generation during infusion of tissue-type plasminogen activator | Q72215676 |
| | Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction | Q72352876 |
| | Is raised plasma fibrinopeptide A a marker of acute coronary insufficiency? | Q72435452 |
| | Mechanisms of thrombin generation during surgery and cardiopulmonary bypass | Q72610515 |
| | Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction | Q72721569 |
| | A sensitive and facile assay for the measurement of activated protein C activity levels in vivo | Q72808557 |
| | Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy | Q33383834 |
| | Measurement of fibrinopeptide A in human blood | Q34463206 |
| | Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency | Q34550218 |
| | Detection of protein C activation in humans | Q34621922 |
| | Protection of factor Xa from neutralization by the heparin-antithrombin complex | Q35207027 |
| | Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study | Q35582687 |
| | Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses | Q35582723 |
| | Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus | Q35902560 |
| | The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity | Q35905116 |
| | The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 |
| | Activation of the hemostatic system during thrombolytic therapy. | Q40800101 |
| | Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group | Q41112658 |
| | Measurement of basal levels of factor VIIa in hemophilia A and B patients | Q41124724 |
| | Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. | Q42460083 |
| | Direct detection of activated protein C in blood from human subjects | Q43803834 |
| | Hypercoagulability in centenarians: the paradox of successful aging. | Q45869145 |
| | Detection of factor X activation in humans | Q45884956 |
| | The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor | Q47962380 |
| | Monitoring "mini-intensity" anticoagulation with warfarin: comparison of the prothrombin time using a sensitive thromboplastin with prothrombin fragment F1+2 levels | Q53395083 |
| | Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. | Q54704880 |
| | Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study | Q57740701 |
| | The isolation and characterization of a specific antibody population directed against the prothrombin activation fragments F2 and F1 + 2 | Q67019140 |
| | Rapid radioimmunoassay of human fibrinopeptide A - removal of cross-reacting fibrinogen with bentonite | Q67250413 |
| | Plasma fibrinopeptide A levels in symptomatic venous thromboembolism | Q67325010 |
| | In vivo and in vitro complexes of activated protein C with two inhibitors in baboons | Q67915179 |
| | Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma | Q67927901 |
| | Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment | Q67945733 |
| | Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes | Q68057790 |
| | Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay | Q68337253 |
| | Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease | Q68485521 |
| | Factor IX is activated in vivo by the tissue factor mechanism | Q68882135 |
| | The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation | Q69117826 |
| | Fibrinopeptide A and platelet factor levels in unstable angina pectoris | Q70019707 |
| | [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin] | Q70038427 |
| | Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency | Q70051608 |
| | D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis | Q70145292 |
| | Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide | Q70194593 |
| | The in vivo metabolism of antithrombin III and antithrombin III complexes | Q70288612 |
| | Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex | Q70332055 |
| | Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity | Q70398354 |
| P433 | issue | 2 | |
| P304 | page(s) | 85-92 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Journal of Thrombosis and Thrombolysis | Q15766541 |
| P1476 | title | Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know | |
| P478 | volume | 2 | |